Vistagen Therapeutics Inc. Common Stock (VTGN)

Stock · NASDAQ · Health Care

$0.25as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Resistance level

$0.60625

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

VTGN
Vistagen Therapeutics Inc. Common Stock
$0.25
▼ 3.85%
Market cap $10.05MP/E —
GDTC
CytoMed Therapeutics Limited Ordinary Shares
$0.92
▼ 4.17%
Market cap $9.50MP/E —
$0.6801$3.68
CNSP
CNS Pharmaceuticals Inc. Common Stock
$5.52
▲ 0.11%
Market cap $8.46MP/E —
$1.9$10.59
SNGX
Soligenix Inc. Common Stock
$0.38
▲ 0.00%
Market cap $8.22MP/E —
$0.28$3.22
PHIO
Phio Pharmaceuticals Corp. Common Stock
$1.13
▲ 0.45%
Market cap $11.97MP/E —
$0.8127$4.19
ADIL
Adial Pharmaceuticals Inc Common Stock
$5.6
▼ 1.41%
Market cap $7.80MP/E —
$1.31$249.81
MTVA
MetaVia Inc. Common Stock
$1.71
▲ 3.01%
Market cap $7.64MP/E —
$0.9661$19.03

Symbol	Market cap	P/E ratio	Price	1D	52-week range
VTGN Vistagen Therapeutics Inc. Common Stock	$10.05M	—	$0.25	▼ 3.85%
GDTC CytoMed Therapeutics Limited Ordinary Shares	$9.50M	—	$0.92	▼ 4.17%	$0.6801$3.68
CNSP CNS Pharmaceuticals Inc. Common Stock	$8.46M	—	$5.52	▲ 0.11%	$1.9$10.59
SNGX Soligenix Inc. Common Stock	$8.22M	—	$0.38	▲ 0.00%	$0.28$3.22
PHIO Phio Pharmaceuticals Corp. Common Stock	$11.97M	—	$1.13	▲ 0.45%	$0.8127$4.19
ADIL Adial Pharmaceuticals Inc Common Stock	$7.80M	—	$5.6	▼ 1.41%	$1.31$249.81
MTVA MetaVia Inc. Common Stock	$7.64M	—	$1.71	▲ 3.01%	$0.9661$19.03

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.